Kezar Life Sciences, Inc. (KZR) Covered Calls

You can sell covered calls on Kezar Life Sciences, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KZR (prices last updated Mon 4:16 PM ET):

Kezar Life Sciences, Inc. (KZR) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.81 -0.04 0.81 0.84 482K - 0.1
Covered Calls For Kezar Life Sciences, Inc. (KZR)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 2.5 0.00 0.84 0.0% 0.0%
Jun 21 2.5 0.00 0.84 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials across five autoimmune indications, including lupus nephritis, autoimmune hemolytic anemia, immune thrombocytopenia, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-616, a selective immunoproteasome inhibitor for the treatment of various autoimmune disease indications; and KZR-TBD for the treatment of oncology and autoimmunity. The company was founded in 2015 and is headquartered in South San Francisco, California.